Wilko non-drowsy decongestant with paracetamol

  • Home
  • Medicine
  • Wilko non-drowsy decongestant with paracetamol
  • image

Wilko non-drowsy decongestant with paracetamol Medicine

Top 20 drugs with the same components:

Actron max Alzaten Cafeina 25% fada Cafeina larjan Cafergot Cafergot (corrective metabolism of bone and cartilaginous tissue) Cafiaspirina (aspirin,caffeine) Geniol (aspirin,caffeine) Ibu evanol (caffeine,ibuprofen) Ibu evanol(+caffeine) Ibupirac migra Ibupirac plus Labsyna caf Labsyna caf (caffeine_ibuprofen) Mejoral cafeina Mejoral cafeina (caffeine_paracetamol) Percutafeine Reanima Reanima (acetaminophen,caffeine) Biragan extra

Contraindications

Hypersensitivity to any component of the preparation.

Pregnant and nursing women.

Undesirable effects

See also:
What are the possible side effects of Wilko Non-Drowsy Decongestant with Paracetamol?

Very rarely (and usually mild) skin rashes and palpitations. Sedation and dizziness may occur after the intake of the yellow (night) tablet. In this case it is not advisable for patients who drive or operate machinery at night. Therefore the yellow tablet is recommended at bedtime.

Therapeutic indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.

Common cold.

Influenza.

Spring catarrh, Rhinorrhea.

Other nasal congestive inflammatory conditions such as allergic rhinitis.

Name of the medicinal product

Wilko Non-Drowsy Decongestant with Paracetamol

Interaction with other medicinal products and other forms of interaction

Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) is metabolized (eliminated by conversion to other chemicals) by the liver. Therefore drugs that increase the action of liver enzymes that metabolize Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) [for example, carbamazepine (Tegretol), isoniazid (INH, Nydrazid, Laniazid), rifampin (Rifamate, Rifadin, Rimactane)] reduce the levels of Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) and may decrease the action of Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol). Doses of Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) greater than the recommended doses are toxic to the liver and may result in severe liver damage. The potential for Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) to harm the liver is increased when it is combined with alcohol or drugs that also harm the liver.

Cholestyramine (Questran) reduces the effect of Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) by decreasing its absorption into the body from the intestine. Therefore, Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) should be administered 3 to 4 hours after cholestyramine or one hour before cholestyramine.

Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) doses greater than 2275 mg per day may increase the blood thinning effect of warfarin (Coumadin) by an unknown mechanism. Therefore, prolonged administration or large doses of Acetaminophen (Wilko Non-Drowsy Decongestant with Paracetamol) should be avoided during warfarin therapy